Pediatrix Medical Group, Inc. (MD)
2025-06-30 | 2025-03-31 | 2024-09-30 | ||
---|---|---|---|---|
Net revenue | 468,844 | 458,359 | 511,158 | |
Transformational and restructuring related expenses | 3,834 | 6,605 | 18,560 | |
Long-lived asset impairments | - | - | - | |
Goodwill impairment | - | - | - | |
General and administrative expenses | 55,714 | 58,604 | 58,121 | |
Loss on disposal of businesses | - | - | -59 | |
Depreciation and amortization | 5,313 | 5,332 | 6,254 | |
Practice supplies and other operating expenses | 20,614 | 18,686 | 29,449 | |
Practice salaries and benefits | 323,502 | 337,031 | 364,888 | |
Total operating expenses | 408,977 | 426,258 | 477,331 | |
Income (loss) from operations | 59,867 | 32,101 | 33,827 | |
Investment and other income (loss) | 3,727 | 4,737 | 1,089 | |
Interest expense | 9,130 | 9,154 | 10,126 | |
Equity in earnings of unconsolidated affiliate | 505 | 406 | 445 | |
Total non-operating expenses | -4,898 | -4,011 | -8,592 | |
Income (loss) before income taxes | 54,969 | 28,090 | 25,235 | |
Income tax (provision) benefit | 15,709 | 7,353 | 5,794 | |
Net income (loss) | 39,260 | 20,737 | 19,441 | |
Unrealized holding gain on investments, net of tax of 140, 66, 395 and 86 | 429 | 779 | 1,745 | |
Total comprehensive income (loss) | 39,689 | 21,516 | 21,186 | |
Basic | 0.46 | 0.25 | 0.23 | |
Diluted | 0.46 | 0.24 | 0.23 | |
Weighted average number of common and common equivalent shares outstanding | 85,529,000 | 85,430,000 | 84,523,000 | |
Weighted average number of common shares outstanding | 84,797,000 | 84,435,000 | 83,891,000 |